Vanderbilt University Medical Center and Stanford University researchers discovered a potent, cross-neutralizing human monoclonal antibody against the respiratory syncytial virus (RSV) and human metapneumovirus (hMPV).
Aug 7, 2023
0
47
The U.S. Centers for Disease Control and Prevention on Thursday recommended that all infants under the age of 8 months be given a new antibody shot to help guard against severe respiratory syncytial virus (RSV).
Aug 4, 2023
0
15
GlaxoSmithKline sued Pfizer on Wednesday over patent infringement, alleging the US drugmaker's RSV vaccine steals key elements of the British company's version.
Aug 2, 2023
0
0
Last year's "tripledemic" of flu, COVID-19 and RSV left many of us wary of what the coming respiratory virus season might bring. But this year's landscape is already different, with new vaccines and treatments, like the game-changing ...
Jul 31, 2023
0
1
Telethon Kids Institute study has suggested the seasonal flu vaccine for children could also protect them from respiratory syncytial virus (RSV), with the dual benefit easing pressure on hospitals.
Jul 27, 2023
0
5
This winter, we're having to get our heads around another respiratory virus—RSV.
Jul 26, 2023
0
1
Europe's drug watchdog on Friday approved the world's first vaccine for infants and those over 60 against the Respiratory Syncytial Virus, a major cause of hospitalization on the continent, the Amsterdam-based agency said.
Jul 21, 2023
0
1
Two vaccines to protect against respiratory syncytial virus (RSV) are now available for those over age 60, but a vaccine to protect young children is still in development. "The Long-Awaited RSV Vaccine" provides an update ...
Jul 21, 2023
0
1
The 2023 flu season is shaping up to be like the influenza season of 2019—the largest on record in Australia.
Jul 19, 2023
0
1
Parents now have a new long-acting drug to protect their children against respiratory syncytial virus (RSV), a common germ that hospitalizes as many as 3% of children under the age of 1 in the United States each year.
Jul 18, 2023
0
7
